Login / Signup

Rhodojaponin VI ameliorates podocyte injury related with MDM2/Notch1 pathway in rat experimental membranous nephropathy.

Anni SongRuiwei YanYue QiuXingjie YinJing XiongGuangmin YaoChun Zhang
Published in: Nephrology (Carlton, Vic.) (2024)
Thus, R-VI ameliorates podocyte injury in rats with PHN, which was probably related with MDM2/Notch1 signalling pathway.
Keyphrases
  • cell proliferation
  • diabetic nephropathy
  • mouse model
  • high glucose
  • drug induced